Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of toxoplasma gondii induces immune response and protection against infection in mice.
about
Interferon-gamma- and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brainRecombinant vaccines against T. gondii: comparison between homologous and heterologous vaccination protocols using two viral vectors expressing SAG1Complex interactions with several arms of the complement system dictate innate and humoral immunity to adenoviral vectors.Effect of codon optimization and subcellular targeting on Toxoplasma gondii antigen SAG1 expression in tobacco leaves to use in subcutaneous and oral immunization in mice.Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans.Pathogen-induced proapoptotic phenotype and high CD95 (Fas) expression accompany a suboptimal CD8+ T-cell response: reversal by adenoviral vaccine.Vaccination using recombinants influenza and adenoviruses encoding amastigote surface protein-2 are highly effective on protection against Trypanosoma cruzi infectionMyD88-dependent protective immunity elicited by adenovirus 5 expressing the surface antigen 1 from Toxoplasma gondii is mediated by CD8(+) T lymphocytes.Toxoplasma gondii superinfection and virulence during secondary infection correlate with the exact ROP5/ROP18 allelic combination.Long-term humoral and cellular immune responses elicited by a heterologous Plasmodium vivax apical membrane antigen 1 protein prime/adenovirus boost immunization protocol.Adenovirus Specific Pre-Immunity Induced by Natural Route of Infection Does Not Impair Transduction by Adenoviral Vaccine Vectors in Mice.Association of a NOD2 gene polymorphism and T-helper 17 cells with presumed ocular toxoplasmosis.Parasite stage-specific recognition of endogenous Toxoplasma gondii-derived CD8+ T cell epitopes.Cellular and molecular physiopathology of congenital toxoplasmosis: the dual role of IFN-gamma.Vaccination against murine toxoplasmosis using recombinant Toxoplasma gondii SAG3 antigen alone or in combination with Quil A.Vaccines against Toxoplasma gondii: challenges and opportunities.Current status of toxoplasmosis vaccine development.Production of recombinant proteins from protozoan parasites.Determination of a Key Antigen for Immunological Intervention To Target the Latent Stage of Toxoplasma gondii.Recombinant vaccines of a CD4+ T-cell epitope promote efficient control of Paracoccidioides brasiliensis burden by restraining primary organ infection.Prizes and parasites: incentive models for addressing Chagas disease.Protective effect of a multiantigenic DNA vaccine against Toxoplasma gondii with co-delivery of IL-12 in mice.Chitosan Microsphere Used as an Effective System to Deliver a Linked Antigenic Peptides Vaccine Protect Mice Against Acute and Chronic Toxoplasmosis.
P2860
Q27011746-D61E6FC0-C399-4ED8-8156-BC7CD982EDEDQ27321063-A51011B0-0B77-4ABF-AFBC-14D01AF28A35Q33380283-A7A02937-C83E-4137-A28C-44B3988D9A54Q33633418-5096522A-DCD1-4A4A-A454-D61134326571Q33956199-64B113DE-02D9-4EF1-AD1B-687C94C7B4D0Q34277020-9037F579-D86E-4A29-A3A1-5529FBF76397Q34700649-C2A62CAF-B1BE-490F-81C7-EF4723EC083EQ35046630-0376F5EB-FA0C-4A62-B9CF-7AA392D55F59Q35172341-305ABFD8-99AC-496F-8308-F32CF23C6380Q35191980-06655163-CC41-40DF-8F41-00C79FE856FAQ35871976-A18C2463-E07F-42DF-8C8F-9D3A855BADDDQ36471061-A583D46D-9073-45F2-B4CD-42793F3BA78AQ36633085-D7B83B08-51DC-4983-8F89-BF5EA8C94508Q36980854-1D0CA727-47F8-4B0A-A39F-9006CE2A82C2Q37065383-96A31E3D-2591-45AC-AE98-077FC38951F3Q37476759-78E10167-2972-4748-8913-CD7D98D8EECAQ37503262-3EBEDB0B-3BCD-4D9A-A18F-362BD2E2A89FQ37699947-DBF1EB30-DCDB-4887-B70E-9508A9B2ECB9Q40236213-BE5D82D9-9E67-4E8E-B140-31411D479501Q41932144-CF81EA70-A700-4DA2-8785-5C5A94B728C3Q47905175-CDC811CD-2158-4525-900C-851939E49A78Q54542831-8E33E536-4E3E-4A56-84B7-B93F769C90E5Q55224227-5F2D1FF5-B1F4-4B4B-A3EC-C59738E491F7
P2860
Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of toxoplasma gondii induces immune response and protection against infection in mice.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Vaccination with replication-d ...... ion against infection in mice.
@en
Vaccination with replication-d ...... ion against infection in mice.
@nl
type
label
Vaccination with replication-d ...... ion against infection in mice.
@en
Vaccination with replication-d ...... ion against infection in mice.
@nl
prefLabel
Vaccination with replication-d ...... ion against infection in mice.
@en
Vaccination with replication-d ...... ion against infection in mice.
@nl
P2093
P356
P1433
P1476
Vaccination with replication-d ...... ion against infection in mice.
@en
P2093
Bráulia C Caetano
Erica A Mendes
Marcus L O Penido
P304
P356
10.1089/HUM.2006.17.415
P577
2006-04-01T00:00:00Z